from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3167c/-

LFCtreatmentdescriptionclass of inhibitor

0.337

Amikacinug/mL Amikacintranslation

-0.202

Cap5-10ug/mL Capreomycintranslation

0.428

Rox10-50 ug/mL Roxithromycintranslation

-0.384

SM2-5 ug/mL Streptomycintranslation

0.460

Tet5-10 ug/mL Tetracyclinetranslation

-0.730

Rif0.2-5ug/mL Rifampicintranscription

-0.470

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.124

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.578

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.200

CPZ10-50 ug/mL Chlorpromazinerespiration

0.959

Clofazimine10-13 ug/mL Clofaziminerespiration

0.110

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.636

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.060

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.420

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.157

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.380

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.547

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.273

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.174

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.390

KCN5-20 ug/mL Potassium cyaniderespiration

0.164

NaN30.2-2 mM Sodium aziderespiration

-0.647

Nigericin50 uM Nigericinrespiration

-0.170

TRC10-150 ug/mL Triclosanrespiration

1.898

TRZ10-25 ug/mL Thioridazinerespiration

1.142

Valinomycin0.5-10 uM Valinomycinrespiration

-0.697

ZnSO42 mM ZnSO4respiration

-0.487

menadione6-10 ug/mL Menadionerespiration

0.322

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.803

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.437

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.335

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.000

NRP_1Non-replicating persistence stage 1dosRassociated

-0.386

Amp0.2mg/mL AmpicillincellWall

0.032

Cephalexin20-100 ug/mL CephalexincellWall

-0.658

Cerulenin0.32-5 ug/mL CerulenincellWall

0.073

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.117

EMB10-20 ug/mL EthambutolcellWall

-0.388

Eta12-40 ug/mL EthionamidecellWall

0.192

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.448

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.350

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.345

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.295

BZA0.12 mg/mL BenzamidearomaticAmides

-0.884

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.211

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.392

H2O24 mM hydrogen peroxideDNAdamaging

0.010

Levo10 ug/mL LevofloxacinDNAdamaging

-0.509

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.916

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.208

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.738

UVUV-irradiationDNAdamaging

1.402

ARP41-4 ug/mL Antitubercular compound ARP4?

0.184

Antimycin12.5-50 ug/mL Antimycin A?

-0.440

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.667

PA_110-50 ug/mL Antitubercular compound PA-1?

0.054

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.781

PA8240.2-2 ug/mL PA-824?

0.431

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.162

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.012

Verapamil50 uM Verapamil?

-0.128

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.155

methoxatin10-20 ug/mL Methoxatin?